May 2017 FDA Recall Drug by American Pharmaceutical Ingredients Llc
D-0937-2017 - CGMP Deviations

This Class II drug recall was voluntarily initiated by American Pharmaceutical Ingredients Llc on May 26, 2017 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0937-2017

Reason for Recall
CGMP Deviations: Lack of quality assurance at the API manufacturer.
Initiated
05-26-2017
Reported
07-12-2017
Quantity
5,000g (5 kg)

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
American Pharmaceutical Ingredients LLC
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500 g container (NDC: 58597-8023-7), c) 1,000 g container (NDC: 58597-8023-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Batch or Lot Expiration Information

Lot# Lots: MCMR1308029NS, MCMR1308029NS-4202015; Exp. 08/18